Definitive Contract 75N91022C00014
Award Date
7/1/22
Potential Completion Date
6/30/32
Potential Value
$112M
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Cancer Institute (NCI) awarded a $55,311,391.18 cost-plus-fixed-fee contract to Technical Resources International, Inc. (TRI) for Drug Development Support for the Cancer Therapy Evaluation Program (CTEP). The contract, which runs through September 30, 2022, provides comprehensive clinical research support services to NCI, including clinical trials execution, regulatory support, research operations, and specialized scientific services. TRI, a minority-owned, woman-owned, and Hispanic...
This is a $171,423,571 cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The contract is for clinical trials sponsor and regulatory management support services to the NCI, its Center for Cancer Research (CCR), and CCR investigators. The services include compliance with regulations, regulatory support,...
This is a $6,443,799.29 cost-plus-fixed-fee contract awarded to Technical Resources International, Inc. (TRI) by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for Cancer Prevention Clinical Trials Auditing and Informatics Support, and does not have a set-aside designation. TRI, a minority-owned, woman-owned, and Hispanic American-owned business, has been awarded over $1.1 billion in federal contracts as a prime contractor,...
This is a firm fixed-price purchase order awarded by the National Cancer Institute (NCI) to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The $119,832 contract provides data and information technology support for the US-Latin American-Caribbean HIV/HPV Prevention Clinical Trials Network (ULACNET) as part of the Clinical Trials Accrual Quality Improvement Program (AQUIP). The contract has no set-aside designation and is...
This is a $164,735,124.00 definitive, cost-plus-fixed-fee contract awarded by the National Cancer Institute (NCI) to Theradex Systems, Inc. to provide broad-based, centralized, and fully integrated operational, administrative, regulatory, information technology, and logistical support services for NCI-supported cancer clinical trials. The contract has a 10-year period of performance from May 1, 2022 to April 30, 2032 and is a re-competition of previous IDIQ contracts. The acquisition is...
This is a $13,175,170.06 cost-plus-fixed-fee Delivery Order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Technical Resources International, Inc. (Technical Resources Intl) for Cancer Prevention Clinical Trials Auditing and Informatics Support services. The contract has a period of performance through May 28, 2020 and was initially awarded on May 30, 2015. Technical Resources Intl is a minority-owned, woman-owned, Hispanic...
This is a $2,139,742.13 cost-plus-fixed-fee federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business. The contract is for a study/chemical-biological research project with an ultimate completion date of August 31, 2007. TRI is an experienced provider of comprehensive clinical research support services to various federal...
This is a cost-plus-fixed-fee delivery order contract awarded to Technical Resources International, Inc. (TRI) by the National Institute on Drug Abuse (NIDA), a civilian federal agency, for a Phase I cocaine drug interaction study as part of the NIDA Pharmacokinetic Analysis Resource Center program. The contract has a ceiling value of $269,663.00 and a period of performance from August 10, 2023 to February 9, 2025, with a projected ultimate completion date of May 31, 2025. TRI is a...
This is a federal contract award to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business, to provide a Pharmacokinetic Analysis Resource Center for the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The contract, with a ceiling value of $416,591.00, has a period of performance from September 1, 2020 to February 28, 2022, and is a cost-plus-fixed-fee Delivery Order. TRI has...
This is a $24,457,189.99 cost-plus-award-fee definitive contract awarded to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, Hispanic American-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID). The contract is for the Regulatory Compliance Center, a set-aside for total small businesses, with a period of performance ending on August 12, 2016. TRI is an experienced provider of comprehensive clinical research support services...